Stock Chart

PSNL

$9.37 -6.02%
Score: 60.0 BUY
LEAPs: SELL $10
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $10
Premium: $1.60
Expiry: Apr 17, 2026
Target: $11
Score: -55

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $9.63 - $10.26 STRONG_UPTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.40
Vol: 0.76x (vs SPY: 0.6x | vs QQQ: 0.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About PSNL - Personalis, Inc. Common Stock

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Key Statistics

Market Cap $832M

This PSNL stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track PSNL's price movements with trendlines, gamma walls, and key support/resistance levels.